advanced search

INJECTION

SENSORS ARE TOOLS – BUT HOW DO YOU MAKE THEM SMART?
CONNECTIVITY
Gaël Senée
Biocorp
SENSORS ARE TOOLS – BUT HOW DO YOU MAKE THEM SMART?
Gaël Senée and Arnaud Guillet explore the benefits of Mallya – a smart sensor that turns conventional injection pens into connected devices. They also discuss the crucial role Biocorp’s connected prefilled syringe, Injay, could play in future COVID-19 vaccination programmes.
APPLYING CONNECTIVITY TO ENHANCE THE TRAINING STANDARD OF CARE FOR SELF-INJECTION
CONNECTIVITY
Erin Miller
Noble
APPLYING CONNECTIVITY TO ENHANCE THE TRAINING STANDARD OF CARE FOR SELF-INJECTION
Erin Miller looks at how connectivity can be used to enhance training to help address the challenges of accuracy and non-adherence when patients self-inject their medications.
INTERVIEW WITH SAI SHANKAR, ADAM SHAIN & MARCUS BATES
INTERVIEW
Sai Shankar
Aptar Pharma
INTERVIEW WITH SAI SHANKAR, ADAM SHAIN & MARCUS BATES
Sai Shankar, Adam Shain and Marcus Bates discuss the full potential of connectivity, coronavirus as a potential accelerator of adoption, and the place of connected drug delivery systems within Aptar Pharma’s broader offering to industry.
MEETING THE CHALLENGES OF COVID-19
CONNECTIVITY
Beo Arana de Martinez
MEETING THE CHALLENGES OF COVID-19
Beo Arana de Martinez and Ilan Shopen discuss the effects of the covid-19 pandemic on patient populations, how the healthcare industry has intensified activity to fight the virus, and how connected devices that facilitate self-injection and remote monitoring are coming into their own.
UNLOCKING INSIGHT FOR PATIENT SUPPORT PROGRAMMES
CONNECTIVITY
Neil Williams
Phillips Medisize
UNLOCKING INSIGHT FOR PATIENT SUPPORT PROGRAMMES
Neil Williams and Andrew Tubb discuss how insights delivered by a cloud-based connected health system help patient support programmes to monitor and improve medication adherence.
CONNECTED DEVICE DATA NEEDED TO MAKE HOME CARE THE STANDARD
EXPERT VIEW
Dr Andrei Yosef
CONNECTED DEVICE DATA NEEDED TO MAKE HOME CARE THE STANDARD
With home care on the increase as a result of the coronavirus pandemic, Andrei Yosef looks at the crucial role played by connected home care medical devices and the data they generate.
EPIWATCH: A NOVEL LIFE-SAVING MICRO AUTOINJECTOR IN A SMART WATCH
EARLY INSIGHT
Amber Witteman
EPIWATCH: A NOVEL LIFE-SAVING MICRO AUTOINJECTOR IN A SMART WATCH
Amber Witteman, Thijs Roebers and Dirk-Jan Opstelten introduce the company’s patented innovation, a wearable autoinjector customised to fit the wrist.
Adding value to Drug Delivery with Connectivity
VIDEO
Kevin Deane
Phillips Medisize
Adding value to Drug Delivery with Connectivity
In this video presentation, Kevin Deane looks at how connectivity applied in drug delivery technologies can provide better solutions for patients and for industry and add value for all stakeholders.
ESTABLISHING DATA-DRIVEN DESIGN AND MANUFACTURING FOR MEDICAL DEVICES
INJECTION
Frederick Gertz
SHL Medical
ESTABLISHING DATA-DRIVEN DESIGN AND MANUFACTURING FOR MEDICAL DEVICES
Frederick Gertz explores the benefits for medical device design and manufacturing organisations of adapting to the use of big data and analytics.
INTERVIEW WITH STEVEN KAUFMAN, STEVANATO & URI BARUCH, CDP
INTERVIEW
Steven Kaufman
Stevanato Group
INTERVIEW WITH STEVEN KAUFMAN, STEVANATO & URI BARUCH, CDP
Steven Kaufman and Uri Baruch discuss the recently announced collaboration between their two companies to accelerate the development of a new variable-dose, cartridge-based pen injector platform for diabetes.
A NOVEL PREFILLABLE SYRINGE WITH A GLASS PRIMARY CONTAINER BUT NO NEED FOR EXTREME THERMAL REFORMING
PREFILLED SYRINGES
Dr Stephen Shue
A NOVEL PREFILLABLE SYRINGE WITH A GLASS PRIMARY CONTAINER BUT NO NEED FOR EXTREME THERMAL REFORMING
Stephen Shue introduces a proprietary prefillable syringe, the SMPFS, whose novel glass-tube-plus-plastic-sheath design enables the use of a standard glass tube primary drug container, but avoids the need for the extreme thermal reforming process that conventional glass prefillable syringes must undergo.
UPDATE ON OXYCAPT MULTILAYER PLASTIC VIAL AND SYRINGE
PREFILLED SYRINGES
Tomohiro Suzuki
Mitsubishi Gas Chemical
UPDATE ON OXYCAPT MULTILAYER PLASTIC VIAL AND SYRINGE
Tomohiro Suzuki gives an update, including new oxygen barrier data, on the development of the OXYCAPT™ multilayer plastic vial and syringe.
SENSOR ADVANCEMENTS IN DRUG DELIVERY IMPROVE COMPLIANCE
EXPERT VIEW
Salvatore Forte
SENSOR ADVANCEMENTS IN DRUG DELIVERY IMPROVE COMPLIANCE
Salvatore Forte discusses various advancements in sensors that are transforming drug delivery systems, making complex devices more automated, easier to use, and improving patient compliance as a result.
Shorter Needles with Thinner Walls to Improve Injection Experience in Chronic Care
PREFILLED SYRINGES
Aurelie Pager
BD (Becton Dickinson & Company)
Shorter Needles with Thinner Walls to Improve Injection Experience in Chronic Care
Aurélie Pager, Brigitte Duinat and Barbara Alves look at how new BD Neopak™ XtraFlow™ prefillable syringes with shorter, 8 mm needles and thinner-wall cannula technology are set to improve the injection experience for subcutaneous drug delivery in chronic care.
WHICH IS THE BETTER TOXICITY TESTING STRATEGY FOR COMBINATION DEVICES?
EXPERT VIEW
Mark Turner
WHICH IS THE BETTER TOXICITY TESTING STRATEGY FOR COMBINATION DEVICES?
Mark Turner explores the issue of toxicity testing for combination devices and asks which is the better testing strategy – ISO 10993 or extractables and leachables?
DESIGN CONSIDERATIONS FOR IMPROVING TRAINING DEVICE SAFETY AND EFFECTIVENESS
EXPERT VIEW
Yvonne Limpens
DESIGN CONSIDERATIONS FOR IMPROVING TRAINING DEVICE SAFETY AND EFFECTIVENESS
Yvonne Limpens and Brenda van Geel, explore the design considerations that need to be taken into account when developing training devices that are safe and effective – and support patients in learning how to administer an injection correctly.
THE NEXT GENERATION OF COATED PLUNGERS
INJECTION
Carina Van Eester
Datwlyer
THE NEXT GENERATION OF COATED PLUNGERS
Carina Van Eester explores the benefits of fully coated plungers for prefilled syringes and cartridges.
APPLICATION OF CFD IN THE DEVELOPMENT OF A WEARABLE BOLUS INJECTOR
WEARABLES
Marcus Hall
APPLICATION OF CFD IN THE DEVELOPMENT OF A WEARABLE BOLUS INJECTOR
Marcus Hall, Björn Ullbrand and Claus Schmidt Møller describe the use of computational fluid dynamics (CFD) as the primary design and analysis tool in the development of a wearable bolus injector.
SUPPORTING IMPROVED PATIENT ONBOARDING & ADHERENCE WITH TRAINING SOLUTIONS
INJECTION
Bill Guilliouma
Noble
SUPPORTING IMPROVED PATIENT ONBOARDING & ADHERENCE WITH TRAINING SOLUTIONS
Bill Guilliouma looks at the role of platform training solutions for patient onboarding and adherence to treatment regimens.
EU MDR DEADLINE DELAY: WHAT DOES IT MEAN FOR THE MEDICAL DEVICE INDUSTRY?
EXPERT VIEW
Beth Crandall
EU MDR DEADLINE DELAY: WHAT DOES IT MEAN FOR THE MEDICAL DEVICE INDUSTRY?
With the compliance deadline for the EU Medical Device Regulation recently delayed by a year due to the novel coronavirus pandemic, Beth Crandall looks at what it means for the medical device industry.
SILICA RE-EMERGES AS POTENTIAL NUCLEIC ACID DELIVERY VECTOR
EXPERT VIEW
Nigel Theobald
SILICA RE-EMERGES AS POTENTIAL NUCLEIC ACID DELIVERY VECTOR
Nigel Theobald looks at the challenges of oligonucleotide delivery and explores approaches to overcome them.
Telemedicine gains acceptance amid the Covid-19 pandemic
Joe Reynolds
Noble
Telemedicine gains acceptance amid the Covid-19 pandemic
Noble highlights how telemedicine is poised to become a mainstream alternative to the traditional in-person methods of care delivery, with the covid-19 pandemic easing barriers to acceptance and introducing patients to the safety and convenience of telehealth technology.
MedinCell investigating role of long-acting antivirals to break chain of SARS-COV-2 viral transmission
MedinCell investigating role of long-acting antivirals to break chain of SARS-COV-2 viral transmission
With evidence indicating that the established antiparasitic ivermectin can kill coronavirus in a laboratory setting in under 48 hours, MedinCell has published data showing that long-acting formulations of ivermectin can be designed with varying doses and durations with its BEPO® technology and is investigating whether a long-acting product could be effective in breaking the chain of viral transmission.
Lexaria Bioscience Expands Pharma Division for development of Lipophilic Antivirals against COVID-19
Lexaria Bioscience Expands Pharma Division for development of Lipophilic Antivirals against COVID-19
Lexaria is to investigate how its patented DehydraTECH drug delivery technology could enhance delivery and effectiveness of certain antiviral drugs in the fight against coronavirus disease COVID-19.  Lexaria intends to expand collaboration with leading laboratories as soon as possible.
Top